Overexpression of SPHK1 and the resulting production of S1P correlated with malignancy, poor prognosis, and shorter survival time in different types of gliomas, especially GBMs (Young and Van Brocklyn, 2007; Li et al., 2022). This evidence concerns the gene SPHK1 and glioma.